Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 23 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

39%

9 trials in Phase 3/4

Results Transparency

6%

1 of 17 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 3
7(50.0%)
Phase 2
3(21.4%)
N/A
2(14.3%)
Phase 4
2(14.3%)
14Total
Phase 3(7)
Phase 2(3)
N/A(2)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials
NCT07267390Completed

Investigating MPXV Viral Clearance in Mpox Cases and Secondary Attack Rate in Contacts

Role: collaborator

NCT06844487Phase 3Active Not Recruiting

Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC

Role: collaborator

NCT07408297Phase 2Completed

Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in Adolescents and Adults Aged 12-64 With and Without HIV in Kenya, DRC, and Rwanda

Role: collaborator

NCT06844500Phase 3Active Not Recruiting

Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC

Role: collaborator

NCT06806956Enrolling By Invitation

Severe Malaria in Remote Areas- Closing the Evidence Gap

Role: collaborator

NCT07355426Completed

Clinical Prediction Models for Pediatric In-Hospital Death Risk in Congolese Severe Malaria Children Using Machine Learning Based-Algorithms

Role: lead

NCT06821282Recruiting

Surveillance of AMR in DRC

Role: collaborator

NCT05514886Completed

Evaluation of Molecular Point-of-care Xpert® Xpress SARS-CoV-2 Detection Implementation in Resource-limited Settings

Role: collaborator

NCT05140278Phase 2Completed

Study to Compare Feasibility of 1-step Injectable Artesunate vs. Conventional 2-step Injectable Artesunate

Role: collaborator

NCT05731297Unknown

Consequences of Sexual Violence Among Women Living in Democratic Republic of Congo

Role: collaborator

NCT05681598Not ApplicableCompleted

Hydroxyurea Treatment for Adult Sickle Cell Anemia Patients in Kinshasa

Role: lead

NCT04186000Phase 2Completed

Study to Evaluate the Immunogenicity and Safety of a Heterologous Vaccine Regimen Against Ebola

Role: collaborator

NCT04783051Phase 3Completed

Comparison of ISTp- PYRAMAX-US-RDT to IPTp-SP to Prevent Malaria in Pregnant Women in DRC (ULTRAPYRAPREG)

Role: lead

NCT04176029Completed

Lung Ultrasound in Children With Severe Malaria

Role: collaborator

NCT03157336Not ApplicableCompleted

Cassava Intervention Project

Role: collaborator

NCT04618523Phase 4Completed

Safety and Efficacy of Recommended Antimalarial in the Democratic Republic of the Congo

Role: collaborator

NCT04424940Unknown

COVID-19 Lessons Learned: the Outcome of TOMEKA® Project is to Teach

Role: lead

NCT02346227Phase 3Completed

Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix

Role: collaborator

NCT02656862Completed

Causes of Acute Undifferentiated Fever in Outpatients in the Democratic Republic of Congo

Role: collaborator

NCT01374581Phase 3Completed

Impact of Artemisinin-based Combination Therapy and Quinine on Treatment Failure and Resistance in Uncomplicated Malaria

Role: collaborator